Topic:
Chutes and Ladders
Latest Headlines
Latest Headlines
Optimer seeking buyout offers as CEO is shown the door
Optimer Pharmaceuticals CEO Pedro Lichtinger has been shown the door, another casualty resulting from an unusual stock deal that took down the company chairman last year. And former Pfizer CEO Henry McKinnell has stepped in as interim chief while the company considers its strategic alternatives--including a possible sale.
Board, Vasella slammed for handling of retirement prize
Like the naughty child that gets caught doing something wrong, Novartis ($NVS) keeps changing its story about just what it is up to. The Swiss company that succumbed to pressure this week and revoked a proposed $78 million non-compete to departing Chairman Daniel Vasella now says it will hire him as a consultant.
Ariad lands Jonathan E. Dickinson as general manager, Europe
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Jennifer Levin ( email | Twitter ) and we will feature it...
Buzz: Shire's new CEO sends mixed signals on 'transformational' M&A strategy
When Shire's new CEO Flemming Ornskov talks, analysts listen. And then some of them talk to Bloomberg . But their stories aren't always consistent.
Ex-Nycomed chief to take chairman's seat at Lundbeck
Björklund had been CEO at the Swiss drugmaker Nycomed, until it sold out to Takeda Pharmaceuticals in 2011.
Ironwood promotes Mark Currie to president of R&D
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant ( email | Twitter ) and we will feature it...
Gregoire exits Shire HGT one step ahead of new CEO's debut
Bright and early today Shire issued an annual report on 2012 brimming with rising sales and bullishly outlining some ambitious late-stage efforts. But as the company prepares to make a high-profile switch in the CEO suite, Shire also announced that Sylvie Gregoire, president of the fast-growing rare-disease division, will step out of her role just as a new CEO is being prepped for the top job.
Jazz CFO joins Medivation's board of directors
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant ( email | Twitter ) and we will feature it...
Layoffs, check. Now, on to hiring--and talent's scarce
More than half of pharma's top executives say it's more difficult to recruit the right people these days, according to a new report from PricewaterhouseCoopers.
Juventas snaps up business development veteran
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant ( email | Twitter ) and we will feature it...
